Back to Andreas Halvorsen
Andreas Halvorsen → TMO via VIKING GLOBAL INVESTORS LP
Andreas Halvorsen TMO Position History
Thermo Fisher Scientific Inc. • Healthcare
Quarters held
8
Latest value
$971.3M
Q2 2026
Peak value
$971.3M
First seen
Q1 2023
Quarter-by-quarter history
Every disclosed snapshot
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $971.3M | 1.94M | — | — |
| Q1 2026 | $819.9M | 1.67M | — | — |
| Q4 2025 | $459.6M | 793.2K | — | — |
| Q1 2024 | $74.7M | 128.5K | — | — |
| Q4 2023 | $285.8M | 538.5K | — | — |
| Q3 2023 | $455.4M | 899.7K | — | — |
| Q2 2023 | $434.7M | 833.2K | — | — |
| Q1 2023 | $493.9M | 856.8K | — | — |